BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 25204977)

  • 1. Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC.
    ; Lachin JM; White NH; Hainsworth DP; Sun W; Cleary PA; Nathan DM
    Diabetes; 2015 Feb; 64(2):631-42. PubMed ID: 25204977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial.
    White NH; Sun W; Cleary PA; Danis RP; Davis MD; Hainsworth DP; Hubbard LD; Lachin JM; Nathan DM
    Arch Ophthalmol; 2008 Dec; 126(12):1707-15. PubMed ID: 19064853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Prior Intensive Insulin Therapy and Risk Factors on Patient-Reported Visual Function Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort.
    ; Gubitosi-Klug RA; Sun W; Cleary PA; Braffett BH; Aiello LP; Das A; Tamborlane W; Klein R
    JAMA Ophthalmol; 2016 Feb; 134(2):137-45. PubMed ID: 26584339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT).
    White NH; Cleary PA; Dahms W; Goldstein D; Malone J; Tamborlane WV;
    J Pediatr; 2001 Dec; 139(6):804-12. PubMed ID: 11743505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic retinopathy and other ocular findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
    Aiello LP;
    Diabetes Care; 2014; 37(1):17-23. PubMed ID: 24356593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents.
    White NH; Sun W; Cleary PA; Tamborlane WV; Danis RP; Hainsworth DP; Davis MD;
    Diabetes; 2010 May; 59(5):1244-53. PubMed ID: 20150283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC).
    Pop-Busui R; Low PA; Waberski BH; Martin CL; Albers JW; Feldman EL; Sommer C; Cleary PA; Lachin JM; Herman WH;
    Circulation; 2009 Jun; 119(22):2886-93. PubMed ID: 19470886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.
    Diabetes; 1995 Aug; 44(8):968-83. PubMed ID: 7622004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of glycemic treatment and microvascular complications on menopause in women with type 1 diabetes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) cohort.
    Kim C; Cleary PA; Cowie CC; Braffett BH; Dunn RL; Larkin ME; Gatcomb PM; Wessells HB; Nathan DM; Sarma AV;
    Diabetes Care; 2014; 37(3):701-8. PubMed ID: 24170751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes.
    ; Nathan DM; Bebu I; Hainsworth D; Klein R; Tamborlane W; Lorenzi G; Gubitosi-Klug R; Lachin JM
    N Engl J Med; 2017 Apr; 376(16):1507-1516. PubMed ID: 28423305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors for Retinopathy in Type 1 Diabetes: The DCCT/EDIC Study.
    Hainsworth DP; Bebu I; Aiello LP; Sivitz W; Gubitosi-Klug R; Malone J; White NH; Danis R; Wallia A; Gao X; Barkmeier AJ; Das A; Patel S; Gardner TW; Lachin JM;
    Diabetes Care; 2019 May; 42(5):875-882. PubMed ID: 30833368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refractive Error and Retinopathy Outcomes in Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.
    Hainsworth DP; Gao X; Bebu I; Das A; Olmos de Koo L; Barkmeier AJ; Tamborlane W; Lachin JM; Aiello LP;
    Ophthalmology; 2021 Apr; 128(4):554-560. PubMed ID: 32941962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.
    ; Lachin JM; Genuth S; Cleary P; Davis MD; Nathan DM
    N Engl J Med; 2000 Feb; 342(6):381-9. PubMed ID: 10666428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on cardiovascular outcomes at 30 years of the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
    Lachin JM; Orchard TJ; Nathan DM;
    Diabetes Care; 2014; 37(1):39-43. PubMed ID: 24356596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study.
    Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group
    JAMA; 2003 Oct; 290(16):2159-67. PubMed ID: 14570951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
    Martin CL; Albers JW; Pop-Busui R;
    Diabetes Care; 2014; 37(1):31-8. PubMed ID: 24356595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights from the diabetes control and complications trial/epidemiology of diabetes interventions and complications study on the use of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes.
    Genuth S
    Endocr Pract; 2006; 12 Suppl 1():34-41. PubMed ID: 16627378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Realising the long-term promise of insulin therapy: the DCCT/EDIC study.
    Nathan DM
    Diabetologia; 2021 May; 64(5):1049-1058. PubMed ID: 33550441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical study of the month. After DCCT, the EDIC study].
    Scheen AJ
    Rev Med Liege; 2000 Mar; 55(3):187-9. PubMed ID: 10823011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview.
    Nathan DM;
    Diabetes Care; 2014; 37(1):9-16. PubMed ID: 24356592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.